Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 30 March - a hint of resilience

Bioventixantibody

The week has started with yet more dividend postponements and cancellations but also some fabulous results from one of the most resilient companies on the stock market.


Bioventix: reliability shines through

Bioventix (LON:BVXP), the developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, has announced excellent interim results for the six months ending 31 December 2019. Revenue rose 21% to £5.3m and pre-tax profit was up 31% to £4.3m. The operating cash inflow was £4m with period end cash £5.5m - cashflows are crucial companies attempt to battle a the period of lockdown.

But Bioventix isn't facing as many challenges as other companies…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Fundamental Asset Management
Buy any of our portfolios with our associates.
 

FIND OUT MORE

Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Become a Champion Investor for just £90 a year.
 
 

START FREE TRIAL

More on Alpha FX Group PLC

Coronavirus impact: 1 Oct - usual plethora of positives from Burford, but….

01/10/2020 · Company Insights

The interim results commentary from Burford Capital contained the usual plethora of positives, but it remains…


Coronavirus impact: 2 Sept - water purification boost to the share price

02/09/2020 · Company Insights

This company's water purification technology and disinfection solution could have multiple applications, including the control of…


More on Bioventix PLC

Coronavirus impact: 19 Oct - boohoo tumbles (again) but others impress

19/10/2020 · Company Insights

While boohoo’s travails continue to dominate the news on AIM, several other fast-growing companies covered here…


Coronavirus impact: 30 March - a hint of resilience

30/03/2020 · Company Insights

The week has started with yet more dividend postponements and cancellations but also some fabulous results…


More on Flowtech Fluidpower Plc

Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more

08/09/2020 · Company Insights

There were a large number of announcements today, including fabulous results from a fast growing provider of…


Coronavirus impact: 28 July - Warhammer maker continues to impress as do others featured here

28/07/2020 · Company Insights

Results today include the usual excellence from two of our AIM favourites and a fantasy miniatures…


More on James Latham

Vaccine countdown update: 25 Nov - a day of frustrating adjustments

25/11/2020 · Company Insights

Listed company results are becoming increasingly hard to understand given the huge number of adjusting items.…


Illegal wages in unsafe working conditions: oh Boohoo!

06/07/2020 · Company Insights

The latest negative publicity for fast fashion group Boohoo calls into question its meteoric share price…


More Company Insights

Data specialist has considerable growth potential in a booming market (Updated)

02/12/2020 · D4t4 Solutions

Is Science in Sport good value at last? (Updated)

02/12/2020 · Science in Sport

Pressure Tech: equity raise to support hydrogen energy growth